Followers

Thursday, January 28, 2021

Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - Topstories https://ift.tt/36lyTbO

No comments:

Post a Comment

Asian tech stocks climb amid mixed signals on tariff reprieve

Technology stocks surged following a temporary pause in tariffs on phones, computers, and consumer electronics, announced by the Trump admin...